Clinical Trial Update: DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for dendritic cell vaccine combined with cytokine-induced killer cells in esophageal cancer (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CIK Cells
• Dendritic cell vaccine

Snippet

Sponsor: Affiliated Hospital to Academy of Military Medical Sciences | Conditions: Esophagus Cancer | Phase 1, Phase 2 | Status: UNKNOWN